Prospective study to evaluate the association between systemic sclerosis and occupational exposure and review of the literature

Autoimmunity Reviews

Volumn 13, Issue 2, 2014, Pages 151-156

  Marie, I ^a,b   Gehanno, J F ^a   Bubenheim, M ^a   Duval Modeste, A B ^a   Joly, P ^a   Dominique, S ^a   Bravard, P ^c   Noel D ^d   Cailleux, A F ^a   Weber, J ^a   Lagoutte, P ^a   Benichou, J ^a   Levesque, H ^a,b  

^a ROUEN UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE ROUEN   (France)

^c LE HAVRE HOSPITAL   (France)

^d CHG Elbeuf   (France)

Author keywords

Crystalline silica; Ketones; Occupational factors; Solvents; Systemic sclerosis; Welding fumes

Indexed keywords

EPOXY RESIN; KETONE; ORGANIC SOLVENT; PENTAZOCINE; PESTICIDE; SILICON DIOXIDE; TOLUENE; TRICHLOROETHYLENE; TRYPTOPHAN; XYLENE;

ADULT; COHORT ANALYSIS; CONTROLLED STUDY; EMPLOYMENT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; REVIEW; RISK ASSESSMENT; SEX DIFFERENCE; SILICONE PROSTHESIS; SMOKING HABIT; SYSTEMIC SCLEROSIS; WELDING FUME;

EID: 84888012841     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2013.10.002     Document Type: Review

References (35)

1. Giuggioli D., Manfredi A., Colaci M., Manzini C.U., Antonelli A., Ferri C. Systemic sclerosis and cryoglobulinemia: our experience with overlapping syndrome of scleroderma and severe cryoglobulinemic vasculitis and review of the literature. Autoimmun Rev 2013, 12:1058-1063.
2. Marie I., Dominique S., Levesque H., Ducrotté P., Denis P., Hellot M.F., et al. Esophageal involvement and pulmonary manifestations in systemic sclerosis. Arthritis Rheum 2001, 45:346-354.
3. Marie I., Gourcerol G., Leroi A.M., Ménard J.F., Levesque H., Ducrotté P. Delayed gastric emptying determined using the 13C-octanoic acid breath test in patients with systemic sclerosis. Arthritis Rheum 2012, 64:2346-2355.
4. Antico A., Tampoia M., Tozzoli R., Bizzaro N. Can supplementation with vitamin D reduce the risk or modify the course of autoimmune diseases? A systematic review of the literature. Autoimmun Rev 2012, 12:127-136.
5. Careta M.F., Leite Cda C., Cresta F., Albino J., Tsunami M., Romiti R. Prospective study to evaluate the clinical and radiological outcome of patients with scleroderma of the face. Autoimmun Rev 2013, 12:1064-1069.
6. Elhai M., Avouac J., Kahan A., Allanore Y. Systemic sclerosis at the crossroad of polyautoimmunity. Autoimmun Rev 2013, 12:1052-1057.
7. Fenoglio D., Bernuzzi F., Battaglia F., Parodi A., Kalli F., Negrini S., et al. Th17 and regulatory T lymphocytes in primary biliary cirrhosis and systemic sclerosis as models of autoimmune fibrotic diseases. Autoimmun Rev 2012, 12:300-304.
8. Jimenez S.A., Piera-Velazquez S. Potential role of human-specific genes, human-specific microRNAs and human-specific non-coding regulatory RNAs in the pathogenesis of systemic sclerosis and Sjögren's syndrome. Autoimmun Rev 2013, 12:1046-1051.
9. Martin P., Teodoro W.R., Velosa A.P., de Morais J., Carrasco S., Christmann R.B., et al. Abnormal collagen V deposition in dermis correlates with skin thickening and disease activity in systemic sclerosis. Autoimmun Rev 2012, 11:827-835.
10. Mehra S., Walker J., Patterson K., Fritzler M.J. Autoantibodies in systemic sclerosis. Autoimmun Rev 2013, 12:340-354.
11. Rossi D., Russo A., Manna E., Binello G., Baldovino S., Sciascia S., et al. The role of nail-videocapillaroscopy in early diagnosis of scleroderma. Autoimmun Rev 2013, 12:821-825.
12. Villalta D., Imbastaro T., Di Giovanni S., Lauriti C., Gabini M., Turi M.C., et al. Diagnostic accuracy and predictive value of extended autoantibody profile in systemic sclerosis. Autoimmun Rev 2012, 12:114-120.
13. Bovenzi M., Barbone F., Pisa F.E., Betta A., Romeo L., Tonello A., et al. A case-control study of occupational exposures and systemic sclerosis. Int Arch Occup Environ Health 2004, 77:10-16.
14. Costenbader K.H., Gay S., Alarcón-Riquelme M.E., Iaccarino L., Doria A. Genes, epigenetic regulation and environmental factors: which is the most relevant in developing autoimmune diseases?. Autoimmun Rev 2012, 11:604-609.
15. Diot E., Lesire V., Guilmot J.L., Metzger M.D., Pilore R., Rogier S., et al. Systemic sclerosis and occupational risk factors: a case-control study. Occup Environ Med 2002, 59:545-549.
16. Garabrant D.H., Lacey J.V., Laing T.J., Gillepsie B.W., Mayes M.D., Cooper B.C. Scleroderma and solvent exposure among women. Am J Epidemiol 2003, 157:493-500.
17. Gómez-Puerta J.A., Gedmintas L., Costenbader K.H. The association between silica exposure and development of ANCA-associated vasculitis: systematic review and meta-analysis. Autoimmun Rev 2013, 12:1129-1135.
18. Nietert P.J., Sutherland S.E., Silver R.M., Pandey J.P., Knapp R.G., Hoel D.G., et al. Is occupational organic solvent exposure a risk factor for scleroderma?. Arthritis Rheum 1998, 41:1111-1118.
19. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980, 23:581-590.
20. LeRoy E.C., Black C., Fleischmajer R., Jablonska S., Krieg T., Medsger T.A., et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988, 15:202-205.
21. Bramwell B. Diffuse scleroderma: its frequency and occurrence in stonemasons; its treatment by fibrinolysin: elevations of temperature due to fibrinolysin injections. Edinb. Med J 1914, 12:387.
22. Erasmus L.D. Scleroderma in goldminers on the Witwatersrand with particular reference to pulmonary manifestations. S Afr Lab Clin Med 1957, 3:209-231.
23. Calvert G.M., Rice F.L., Boiano J.M., Sheehy J.W., Sanderson W.T. Occupational silica exposure and risk of various diseases: an analysis using death certificates from 27 states of the United States. Occup Environ Med 2003, 60:122-129.
24. Englert H., O'connor H., Small-McMahon J., Chambers P., Davis K., Brooks P. Male systemic sclerosis and occupational silica exposure - a population based study. Aust N Z J Med 2000, 30:215-220.
25. Silman A.J., Jones S. What is the contribution of occupational environmental factors to the occurrence of scleroderma in men?. Ann Rheum Dis 1992, 51:1322-1324.
26. Sluis-Cremer G.K., Hassel P.A., Nizdo E.H., Churchill A.R., Zeiss E.A. Silica, silicosis and progressive systemic sclerosis. Br J Ind Med 1985, 41:838-843.
27. Haustein U.F., Ziegler V., Hermann K., Mehlhorn J., Schmidt C. Silica-induced scleroderma. J Am Acad Dermatol 1990, 22:444-448.
28. Miller F.W., Alfredsson L., Costenbader K.H., Kamen D.L., Nelson L.M., Norris J.M., et al. Epidemiology of environmental exposures and human autoimmune diseases: findings from a National Institute of Environmental Health Sciences Expert Panel Workshop. J Autoimmun 2012, 39:259-271.
29. Reinl W. Sklerodermie durch trichloräthylen-einwirkung?. Zent Arb Arb 1957, 7:58-60.
30. Kettaneh A., Al M.O., Tiev K.P., Chayet C., Toledano C., Fabre B., et al. Occupational exposure to solvents and gender-related risk of systemic sclerosis: a metaanalysis of case-control studies. J Rheumatol 2007, 34:97-103.
31. Maître A., Hours M., Bonneterre V., Arnaud J., Tülin-Arslan M., Carpentier P., et al. Systemic sclerosis and occupational risk factors: role of solvents and cleaning products. J Rheumatol 2004, 31:2395-2401.
32. Cooper G.S., Makris S.L., Nietert P.J., Jinot J. Evidence of autoimmune-related effects of trichloroethylene exposure from studies in mice and humans. Environ Health Perspect 2009, 117:696-702.
33. Ishikawa O., Warita S., Tamura A., Miyachi Y. Occupational scleroderma. A 17-year follow-up study. Br J Dermatol 1995, 133:786-789.
34. Cooper G.S., Parks C.G., Treadwell E.L., St Clair E.W., Gilkeson G.S., Dooley M.A. Occupational risk factors for the development of systemic lupus erythematosus. J Rheumatol 2004, 31:1928-1933.
35. De Roos A.J., Cooper G.S., Alavanja M.C., Sandler D.P. Rheumatoid arthritis among women in the agricultural health study: risk associated with farming activities and exposures. Ann Epidemiol 2005, 15:762-770.